Intra Cellular Therapies | Tillgångar



Assets Ändra Datum
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
ALKERMES USD 2.06B 99.72M 2024-12
Biogen USD 28.05B 263.9M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Cytokinetics USD 1.4B 34.39M 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Intra Cellular Therapies USD 1.37B 42.47M 2024-12
J&J USD 180.1B 1.82B 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Prothena USD 547.11M 48.15M 2024-12
RedHill Biopharma USD 22.02M 4K 2024-06
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12



Intra Cellular Therapies Tillgångar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.